Overview

Dual Trigger Versus Booster Dose of HCG

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
To salvage the luteal phase and improve pregnancy rate in antagonist IVF/ICSI cycles triggered with GnRH agonist. Two strategies are compared dual trigger with GnRH agonist plus 1000 IU of HCG or triggering with GnRH and giving a booster dose of HCG (1500 IU) on the day of ovum pickup.
Phase:
N/A
Details
Lead Sponsor:
Cairo University
Collaborators:
Adam International Hospital
Nile Ivf Center, Cairo, Egypt
Treatments:
Chorionic Gonadotropin
Deslorelin